Literature DB >> 18090228

Preferential increase of extracellular matrix expression relative to transforming growth factor beta1 in the pancreas during the early stage of acute hemorrhagic pancreatitis in rats.

Hayato Nakamura1, Mitsuo Tashiro, Taizo Yamaguchi, Hiroshi Asaumi, Yoko Nomiyama, Shiro Watanabe, Yoshikuni Nagashio, Tamao Miyamoto, Makoto Otsuki.   

Abstract

OBJECTIVES: To elucidate the role of transforming growth factor (TGF) beta1 and extracellular matrix (ECM) after acute necrotizing pancreatitis, we studied the regulation of TGF-beta1 and ECM after induction of pancreatitis.
METHODS: We examined the serial changes of levels of plasma TGF-beta1 by enzyme-linked immunoassay and expression of TGF-beta1 and ECM by Northern and Western blot analyses, respectively, in the pancreas after induction of sodium taurocholate-induced acute pancreatitis.
RESULTS: Plasma total (active and inactive) TGF-beta1 levels at 3 hours after induction of pancreatitis were significantly increased compared with baseline values. The levels of TGF-beta1 messenger RNA (mRNA) were unaltered by day 2. Levels of fibronectin mRNA at 3 hours after induction of pancreatitis were already higher than the baseline values. Latency-associated peptide-TGF-beta1 showed a peak on day 7. Thus, the expression of ECM mRNA increased earlier than that of TGF-beta1 mRNA.
CONCLUSIONS: These results suggest that the increase in plasma TGF-beta1 concentration probably results from the elevated secretion of TGF-beta1 from several cells and/or the redistribution of TGF-beta1 protein and that the increase in expression of ECM probably is associated with the activation of TGF-beta1. It is conceivable that both increased plasma concentration and focal activation of TGF-beta1 play an important role in ECM production during the early stage of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18090228     DOI: 10.1097/mpa.0b013e318120020d

Source DB:  PubMed          Journal:  Pancreas        ISSN: 0885-3177            Impact factor:   3.327


  2 in total

Review 1.  Extracellular Matrix Scaffold Technology for Bioartificial Pancreas Engineering: State of the Art and Future Challenges.

Authors:  Marcus Salvatori; Ravi Katari; Timil Patel; Andrea Peloso; Jon Mugweru; Kofi Owusu; Giuseppe Orlando
Journal:  J Diabetes Sci Technol       Date:  2014-01-01

2.  Galunisertib (LY2157299), a transforming growth factor-β receptor I kinase inhibitor, attenuates acute pancreatitis in rats.

Authors:  X Liu; M Yu; Y Chen; J Zhang
Journal:  Braz J Med Biol Res       Date:  2016-08-08       Impact factor: 2.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.